gw8510 has been researched along with Lung Neoplasms in 2 studies
GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P | 1 |
| Wu, JN | 1 |
| Shu, Y | 1 |
| Jiang, HG | 1 |
| Zhao, XH | 1 |
| Qian, H | 1 |
| Chen, K | 1 |
| Lan, T | 1 |
| Chen, CG | 1 |
| Li, J | 1 |
| Dong, F | 1 |
| Guo, W | 1 |
| Zhang, L | 1 |
| Wu, S | 1 |
| Teraishi, F | 1 |
| Davis, JJ | 1 |
| Fang, B | 1 |
2 other studies available for gw8510 and Lung Neoplasms
| Article | Year |
|---|---|
Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction.
Topics: Animals; Antimetabolites, Antineoplastic; Autophagy; Carcinoma, Squamous Cell; Deoxycytidine; Down-R | 2018 |
Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cyclin-Dependent Kinases; Down-Regulation; Humans; Indole | 2006 |